Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dechra Pharmaceuticals Plc (DPH.LN)

Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dechra Pharmaceuticals Plc 24 Cheshire Avenue Cheshire Business Park Northwich CW9 7UA GBR

https://www.dechra.com P: 160-681-4730 F: 160-681-4731

Description:

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Key Statistics

Overview:

Market Capitalization, $K 4,403,602
Shares Outstanding, K 113,906
Annual Sales, $ 761,500 K
Annual Net Income, $ -27,900 K
% of Insider Shareholders 1.90%
% of Institutional Shareholders 29.38%

Growth:

1-Year Return 29.82%
3-Year Return 5.28%
5-Year Return 65.92%
5-Year Revenue Growth 13.34%
5-Year Dividend Growth 14.91%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.25
Annual Dividend Rate, $ 0.45
Most Recent Dividend 0.125 on 03/09/23
Next Ex-Dividends Date 03/09/23
Dividend Payable Date 04/13/23
Dividend Payout Ratio 0.00%

DPH.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -3.92%
Return-on-Assets % -1.95%
Profit Margin % -3.66%
Debt/Equity 0.66
Price/Sales 5.79
Price/Book 5.83
Book Value/Share 6.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar